A Resource for Healthcare and Social Services Professionals
Estimated time to complete: 30 minutes
This training will provide an overview of the intersection of substance use disorders and those involved with the criminal legal system.
This training describes the principles of harm reduction and offers strategies to support persons who use drugs and their community members.
This training satisfies 0.50 hours of the required 8 hours of training for DEA-registered practitioners. The Medication Access and Training Expansion (MATE) Act was included in the Consolidated Appropriations Act, 2023. The MATE Act requires increased training for Drug Enforcement Administration (DEA)-registered physicians and practitioners—specifically, a one-time eight-hour training requirement on treating and managing patients with opioid or other substance use disorders.
Medical professionals with prescriptive authority, nurses and support staff who support them looking to increase provision of care for patients with substance use disorder.
Daniel P. Alford, MD, MPH, FACP, FASAM, CME Course Director, has no relevant financial relationships to disclose.
Colleen LaBelle, Planning Committee
Ilana Hardesty, MA, Planning Committee
Victoria Rust, BS, Planning Committee
Members of the planning committee have no relevant financial relationships to disclose.
Sharif Nankoe, MD, MPA, MA, FASAM
Dr. Nankoe is the Chief Medical Director for Department of Corrections (DOC) Programs at Spectrum Health Systems, a private nonprofit behavioral health organization in Massachusetts. He oversees, directs, and implements medical operations for Massachusetts DOC-based medication for opioid use disorder programs. He previously served as the medical director for the Vermont DOC Medication-Assisted Treatment Program and worked in the Vermont Hub and Spoke system as the Medical Director of two Hubs (methadone outpatient treatment programs) and two Spokes (office-based opioid treatment clinics).
Dr. Nankoe has no relevant financial relationships to disclose.
Following this training, participants will have the knowledge necessary to:
Boston Medical Center Grayken Center for Addiction Training and Technical Assistance, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
To earn credit, one must complete the pre-test, video, and pass the post-test evaluation. The evaluation closes two weeks after watching the video.
Continuing Medical Education (CME)
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date of Release: 7/11/23
Date of Expiration: 7/11/24
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.
Faculty members do not plan on discussing off-label/investigational uses of a commercial product.
THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
Contact Hours for Nurses
Boston Medical Center is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Participants who complete the entire session, return the evaluation, and pass the post-test with a score of 70% will be awarded 0.50 contact hours, 0.25 of which are classified as pharmacology.
This course expires on 7/14/2024
None of the planners or speakers have a financial relationship to disclose with ineligible companies.